Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,814
-$39,101 QoQ
Shares Held
6,019
-5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,772
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COZAD ASSET MANAGEMENT INC holds $35,468,302 across 7 Drug Manufacturers - General names. BMY ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,746 | $28,481,667 | |
| 2 | JNJ |
Johnson & Johnson
|
17,475 | $4,438,125 | |
| 3 | PFE |
Pfizer Inc
|
35,997 | $866,807 | |
| 4 | AMGN |
Amgen Inc
|
1,667 | $603,654 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,012 | $506,876 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
6,019 | $346,814 | |
| 7 | NVO |
Novo Nordisk A S
|
4,680 | $224,359 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,814 | 6,019 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $385,915 | 6,363 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $343,220 | 6,363 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $294,593 | 6,532 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $302,366 | 6,532 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $387,713 | 6,357 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $362,379 | 6,407 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $308,991 | 5,972 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $252,834 | 6,088 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $382,755 | 7,058 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $406,016 | 7,913 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $540,584 | 9,314 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $634,064 | 9,915 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $696,496 | 10,049 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $705,829 | 9,810 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $559,336 | 7,868 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $606,529 | 7,877 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $573,577 | 7,854 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $399,289 | 6,404 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $385,788 | 6,520 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $479,099 | 7,170 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $492,098 | 7,795 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $530,852 | 8,558 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $600,066 | 9,953 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $585,177 | 9,952 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $564,869 | 10,134 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||